Nausea and vomiting in advanced cancer

American Journal of Hospice and Palliative Medicine

Volumn 27, Issue 3, 2010, Pages 219-225

  Ang, Sik Kim ^a   Shoemaker, Laura K ^a   Davis, Mellar P ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Cancer; Nausea; Vomiting

Indexed keywords

ANTIEMETIC AGENT; INDOLE DERIVATIVE; METOCLOPRAMIDE; SEROTONIN ANTAGONIST; TROPISETRON;

ALGORITHM; ANAMNESIS; ARTICLE; DECISION TREE; DRUG COMBINATION; EPIDEMIOLOGY; EVIDENCE BASED MEDICINE; GASTROSTOMY; HUMAN; INTESTINE OBSTRUCTION; METHODOLOGY; NAUSEA; NEOPLASM; PATIENT SELECTION; PHYSICAL EXAMINATION; STOMACH PARESIS; VOMITING;

ALGORITHMS; ANTIEMETICS; CAUSALITY; DECISION TREES; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; GASTROPARESIS; GASTROSTOMY; HUMANS; INDOLES; INTESTINAL OBSTRUCTION; MEDICAL HISTORY TAKING; METOCLOPRAMIDE; NAUSEA; NEOPLASMS; PATIENT SELECTION; PHYSICAL EXAMINATION; RESEARCH DESIGN; SEROTONIN ANTAGONISTS; VOMITING;

EID: 77952145182     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/1049909110361228     Document Type: Article

References (38)

1. Twycross R., Back I. Nausea and vomiting in advanced cancer. Eur J Pall Care. 1998;5:39-45.
2. Davis MP, Walsh D. Treatment of nausea and vomiting in advanced cancer. Support Care Cancer. 2000;8(6):444-452.
3. Stephenson J., Davies A. An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer. 2006;14(4):348-353.
4. Bentley A., Boyd K. Use of clinical pictures in the management of nausea and vomiting: a prospective audit. Palliat Med. 2001; 15(3):247-53.
5. Lichter I. Results of antiemetic management in terminal illness. J Palliat Care. 1993;9(2):19-21.
6. Kinghorn S. Palliative care. Nausea and vomiting. Nurs Times. 1997;93(33):57-60.
7. Axelrod RS Antiemetic therapy. Compr Ther. 1997;23(8):539-45.
8. Mystakidou K., Befon S., Liossi C., Vlachos L. Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer. Cancer. 1998;83(6):1214-23.
9. Hardy J., Daly S., McQuade B., Albertsson M., Chimontsi-Kypriou V., Stathopoulos P.,et al.A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients. Support Care Cancer. 2002; 10(3):231-6.
10. Glare P., Pereira G., Kristjanson LJ, Stockler M., Tattersall M. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer. Support Care Cancer. 2004;12(6):432-40.
11. Bruera E., Belzile M., Neumann C., Harsanyi Z., Babul N., Darke A. A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage. 2000;19(6):427-35.
12. Bruera E., Seifert L., Watanabe S., Babul N., Darke A., Harsanyi Z.,et al.Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. J Pain Symptom Manage. 1996;11(3):147-53.
13. Bruera ED, MacEachern TJ, Spachynski KA, LeGatt DF, MacDonald RN, Babul N.,et al.Comparison of the efficacy, safety, and pharmacokinetics of controlled release and immediate release metoclopramide for the management of chronic nausea in patients with advanced cancer. Cancer. 1994;74(12):3204-11.
14. Feuer DJ, Broadley KE Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev. 2000;2(2): CD001219.
15. Ripamonti C., Mercadante S., Groff L., Zecca E., De Conno F., Casuccio A. Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage. 2000;19(1):23-34.
16. Mystakidou K., Tsilika E., Kalaidopoulou O., Chondros K., Georgaki S., Papadimitriou L. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial. Anticancer Res. 2002;22(2B):1187-92.
17. Twycross R., Bankby G., Hallowood J. The use of low-dose methotrimeprazine (levopromazine) in the management of nausea and vomiting. Prog Palliat Care. 1997;5:49-53.
18. Eisenchlas JH, Garrigue N., Junin M., De Simone GG Low-dose levomepromazine in refractory emesis in advanced cancer patients: an open-label study. Palliat Med. 2005;19(1):71-5.
19. Homburger F., Smithy G. Chlorpromazine in patients with nausea and vomiting due to advanced cancer. N Engl J Med. 1954; 251(20):820-2.
20. Mystakidou K., Befon S., Liossi C., Vlachos L. Comparison of tropisetron and chlorpromazine combinations in the control of nausea and vomiting of patients with advanced cancer. J Pain Symptom Manage. 1998;15(3):176-84.
21. Homburger F., Smithy G. Proclorperazine for the treatment of nausea and vomiting in patients with advanced cancer and other chronic diseases. N Engl J Med. 1957;256(1):27.
22. Fagnano G., Cristofari U. Use of prochlorperazine as adjuvant in therapy of secondary phenomena in cancer patients. Minerva Med. 1959;50(44):1748-9.
23. Homburger F. Perphenazine as an antiemetic agent in cancer and other chronic diseases. J Am Med Assoc. 1958;167(10):1240-1.
24. Lichter I. Which antiemetic? J Palliat Care. 1993;9(1):42-50.
25. Jackson WC, Tavernier L. Olanzapine for intractable nausea in palliative care patients. J Palliat Med. 2003;6(2):251-5.
26. Passik SD, Lundberg J., Kirsh KL, Theobald D., Donaghy K., Holtsclaw E.,et al.A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain. J Pain Symptom Manage. 2002;23(6):526-32.
27. McCawley EL, Kulasavage RJ, Warrington WR, Pasquesi TJ The intravenous use of diphenhydramine hydrochloride in the control of nausea and vomiting. Portland Clin Bull. 1951;5(3):43-8.
28. Critchley P., Plach N., Grantham M., Marshall D., Taniguchi A., Latimer E. Efficacy of haloperidol in the treatment of nausea and vomiting in palliative patient: a systemic review (letter). J Pain Symptom Manage. 1995;10:521-526.
29. Ventafridda V., Ripamonti C., Caraceni A., Spoldi E., Messina L., De Conno F. The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori. 1990;76(4): 389-93.
30. Gonzalez-Rosales F., Walsh D. Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol). J Pain Symptom Manage. 1997;14(5):311-4.
31. Sorensen JB, Andersen MK, Hansen HH Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. J Intern Med. 1995;238(2):97-110.
32. Hussain I., MacKellar A., Knowles GK Rectal administration of demeclocycline in a patient with the syndrome of inappropriate ADH secretion. Int J Clin Pract. 1998;52(1):59.
33. Ripamonti C., Twycross R., Baines M., Bozzetti F., Capri S., De Conno F.,et al.Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer. 2001;9(4):223-33.
34. Mercadante S., Ferrera P., Villari P., Marrazzo A. Aggressive pharmacological treatment for reversing malignant bowel obstruction. J Pain Symptom Manage. 2004;28(4):412-6.
35. Mackey R., Chand B., Oishi H., Kameoka S., Ponsky JL Percutaneous transesophageal gastrostomy tube for decompression of malignant obstruction: report of the first case and our series in the US. J Am Coll Surg. 2005;201(5):695-700.
36. Davis MP, Frandsen J., Dickerson E., Ripamonti C. Prescribing for the actively dying patient: principles and practice. J Term Oncol. 2002;1:19-32.
37. Kennett A., Hardy J., Shah S., A'Hern R. An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer. Support Care Cancer. 2005; 13(9):715-21.
38. Srivastava M., Brito-Dellan N., Davis MP, Leach M., Lagman R. Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer. J Pain Symptom Manage. 2003;25(6):578-82.